drugset / Trial / NCT02109497
Phase 1 Study to Determine the Effects of PBT2 on the Pharmacokinetic Profile of Caffeine
NaSingle-groupOpen-labelBasic science
Summary
This study is designed to determine the pharmacokinetic (PK) profile of a single oral dose of caffeine and the effects that PBT2 has on the metabolism of caffeine in healthy volunteers.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-06
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PBT2 | Small molecule | 250 mg | — |
Indications
No indication recorded.